Anticancer properties of propofol-docosahexaenoate and propofol-eicosapentaenoate on breast cancer cells
about
Cell membrane modulation as adjuvant in cancer therapyEffect of opiates, anesthetic techniques, and other perioperative factors on surgical cancer patients.Monoacylglycerol lipase exerts dual control over endocannabinoid and fatty acid pathways to support prostate cancer.Mini profile of potential anticancer properties of propofol.Metformin-induced killing of triple-negative breast cancer cells is mediated by reduction in fatty acid synthase via miRNA-193bModulation of lipid rafts by Omega-3 fatty acids in inflammation and cancer: implications for use of lipids during nutrition support.Propofol induces apoptosis and increases gemcitabine sensitivity in pancreatic cancer cells in vitro by inhibition of nuclear factor-κB activityMinerval induces apoptosis in Jurkat and other cancer cells.Antineoplastic effects of n-3 polyunsaturated fatty acids in combination with drugs and radiotherapy: preventive and therapeutic strategies.Choice of anesthetic technique on plasma concentrations of interleukins and cell adhesion molecules.Enhancing cytotoxic therapies for breast and prostate cancers with polyunsaturated fatty acids.Possible link between cyclooxygenase-inhibiting and antitumor properties of propofol.Propofol suppresses proliferation and invasion of glioma cells by upregulating microRNA-218 expression.Biophysical Interactions of Novel Oleic Acid Conjugate and its Anticancer Potential in HeLa Cells.A fatty acid-binding protein 7/RXRβ pathway enhances survival and proliferation in triple-negative breast cancer.How plausible is the use of dietary n-3 PUFA in the adjuvant therapy of cancer?In vivo effects of different anesthetic agents on apoptosisPropofol enhances BCR-ABL TKIs' inhibitory effects in chronic myeloid leukemia through Akt/mTOR suppression.Omega-3 but not omega-6 unsaturated fatty acids inhibit the cancer-specific ENOX2 of the HeLa cell surface with no effect on the constitutive ENOX1.Anticancer efficacy of a novel propofol-linoleic acid-loaded escheriosomal formulation against murine hepatocellular carcinoma.Evaluation of cytotoxicity of propofol and its related mechanism in glioblastoma cells and astrocytes.Best practice in the administration of analgesia in postoncological surgery.Propofol induces apoptosis of hepatocellular carcinoma cells by upregulation of microRNA-199a expression.Propofol Inhibits HeLa Cells by Impairing Autophagic Flux via AMP-Activated Protein Kinase (AMPK) Activation and Endoplasmic Reticulum Stress Regulated by Calcium.Effect of Propofol on breast Cancer cell, the immune system, and patient outcome.
P2860
Q28078167-3C63F6A6-5020-488F-A726-7FA589865769Q33737523-CCB7A2B1-13E1-4EA8-A569-254C7D943A27Q35146525-D265FD6E-9E61-4B69-B6F0-CC03D865F6E9Q35515984-D751F064-D33C-4F08-9291-41C0E5E2CF30Q36062114-3687ACC3-EA3B-4C04-AD0A-F84A7F46B6EFQ36715129-D94FE379-9FB9-4242-9814-1EDB87574419Q37142216-3A1B7D5A-3E31-4E9A-AAA9-42A8B3C932E7Q37296326-C8831C6C-F5DE-4BC6-AD19-D82A6C750937Q37448363-4A6F14DB-920C-4DB2-812F-8FE2E15599D6Q37660558-279A950B-2E6E-4C61-9910-E1E76DAA9EDFQ37722636-162B3995-6473-4626-8C4B-2BDAA6BEF970Q37879601-FDE2A50F-1DE7-4D07-BE7D-E25F72C85EC4Q38858088-0DD24514-654F-4697-B2CA-E182BA59CE8DQ38914546-5D02E5F6-767D-4C69-9B0C-BD7C36274231Q39398659-6E57A298-73EE-42BB-9995-27953EDC194AQ39771420-149A8454-C62E-4113-B5E0-79B43E652A0EQ42255703-12368D72-8960-4271-A627-98AAB89D0588Q42368110-608C7F1C-7497-44F8-9ACB-A6C541928B3FQ42720315-82F47684-E381-497A-915F-08011D3455ACQ43512157-F4D3BAD4-269B-452F-834D-6D076806F91AQ46321602-B8689D06-47F0-4BD4-BCD5-642E891DA3F7Q47689970-11676F82-36EB-40BF-8998-14E9BEA5B1F5Q48098922-5600EFC6-4EC8-4411-9CA5-B4CA19AA6746Q52581135-8B402902-95F7-4F69-9CB4-87BC76211316Q55425616-7B78A297-928F-43D9-92E9-85BA26524916
P2860
Anticancer properties of propofol-docosahexaenoate and propofol-eicosapentaenoate on breast cancer cells
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Anticancer properties of propo ...... aenoate on breast cancer cells
@ast
Anticancer properties of propo ...... aenoate on breast cancer cells
@en
Anticancer properties of propo ...... aenoate on breast cancer cells
@nl
type
label
Anticancer properties of propo ...... aenoate on breast cancer cells
@ast
Anticancer properties of propo ...... aenoate on breast cancer cells
@en
Anticancer properties of propo ...... aenoate on breast cancer cells
@nl
prefLabel
Anticancer properties of propo ...... aenoate on breast cancer cells
@ast
Anticancer properties of propo ...... aenoate on breast cancer cells
@en
Anticancer properties of propo ...... aenoate on breast cancer cells
@nl
P2093
P2860
P356
P1476
Anticancer properties of propo ...... aenoate on breast cancer cells
@en
P2093
Alicia Castillo
Gary P Zaloga
Kevin Harvey
Mustapha Zerouga
Rafat A Siddiqui
William Stillwell
P2860
P2888
P304
P356
10.1186/BCR1036
P407
P577
2005-06-07T00:00:00Z
P5875
P6179
1006054261